No Data
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential
Express News | HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target
Sector Update: Health Care Stocks Mixed Premarket Monday
Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year
Express News | Cybin Inc - Initiates Phase 3 Paradigm Program for Cyb003